News

When Myeloma Returns, a New Treatment Is Changing the Odds

Jun 19, 2026 in Multiple Myeloma

A Conversation With Biotech Firm Erasca's Chief Medical Officer On What Patients Should Know About the Growing Momentum Behind A New Class Of Oncology Drugs

Jun 19, 2026

'If Our Innovation Doesn't Reach the Patient, Then What Are We Doing?' Drugmaker Bayer's Tara Frenkl On The Company's Patient-First Oncology Mission

Jun 17, 2026

A New Drug Cuts the Risk of Early-Stage Lung Cancer Coming Back by 83%

Jun 16, 2026 in Lung Cancer

Johnson & Johnson’s Mark Wildgust on Putting Patients First in Cancer Care

Jun 16, 2026 in Prostate Cancer

For High-Risk Lymphoma, Adding Targeted Drugs Tafasitamab And Lenalidomide To Standard Treatment Keeps Cancer Controlled For Longer

Jun 15, 2026 in Non-Hodgkin Lymphoma

New Treatments for Ovarian Cancer Are Changing the Game And Doctors Are Moving Fast

Jun 14, 2026 in Ovarian Cancer

Hopeful, Deeply Dedicated, & Investing In Hard-to-Treat Cancers: The View From Drugmaker Astellas' Moitreyee Chatterjee-Kishore

Jun 11, 2026

More Than Half of ALK-Positive Lung Cancer Patients Still Stable After 7 Years on Lorlatinib

Jun 11, 2026 in Lung Cancer

Skin Cancer Survivor, 26, Encourages 'SPF Every Day' After 'Blocked Pore' Led To Diagnosis

Jun 11, 2026 in Melanoma

Advancing the Future of Cancer Care: Gilead's Chief Medical Officer on The Commitment Needed To Enable More Effective Treatments

Jun 10, 2026

Experimental Drug Gedatolisib Shows Promise For Patients With Advanced Breast Cancer After Treatment Stops Working

Jun 10, 2026 in Breast Cancer